Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Novartis Investigative Site, Kogarah

Novartis Investigative Site, Parkville

Novartis Investigative Site, South Brisbane

Novartis Investigative Site, Ghent

Queens Cancer Center of Queens Hospital, Jamaica

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

NorthWest Georgia Oncology Centers Marietta Center, Marietta

Novartis Investigative Site, Toulouse

MD Anderson Cancer Center - Orlando CEPO906A2229, Orlando

Novartis Investigative Site, Bordeaux

Palm Beach Cancer Institute, West Palm Beach

H. Lee Moffitt Cancer Center/University of South Florida Department of Genitourology, Tampa

Novartis Investigative Site, Valencia

Novartis Investigative Site, Lille

University Chicago Hospital StudyCoordinator:CEPO906A2229, Chicago

Novartis Investigative Site, Strasbourg

Novartis Investigative Site, Colmar

Novartis Investigative Site, Mannheim

Novartis Investigative Site, Rouen

University of Colorado Dept. of Univ. of Colorado, Aurora

Novartis Investigative Site, Weiden

Oregon Health & Science University StudyCoordinator:CEPO906A2229, Portland

Novartis Investigative Site, Singapore

University of California San Diego Dept of Moores Cancer Center, La Jolla

Norwalk Hospital, Norwalk

Georgetown University/Lombardi Cancer Center Dept.of Lombardi Cancer Center, Washington D.C.

Novartis Investigative Site, Perugia

Novartis Investigative Site, Barcelona